| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| ADAM Proteins | 6 | 2014 | 53 | 1.200 |
Why?
|
| Kidney Tubules, Collecting | 5 | 2014 | 46 | 0.620 |
Why?
|
| Saponins | 2 | 2004 | 13 | 0.490 |
Why?
|
| Mesangial Cells | 2 | 2012 | 37 | 0.480 |
Why?
|
| ADAM17 Protein | 7 | 2017 | 28 | 0.480 |
Why?
|
| Mitochondria | 5 | 2022 | 643 | 0.440 |
Why?
|
| Integrin alpha5beta1 | 1 | 2012 | 9 | 0.430 |
Why?
|
| NAD | 2 | 2022 | 73 | 0.400 |
Why?
|
| Epithelial Cells | 3 | 2015 | 431 | 0.380 |
Why?
|
| Mitochondrial Membranes | 2 | 2020 | 45 | 0.360 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 5 | 2014 | 175 | 0.360 |
Why?
|
| Polycystic Kidney Diseases | 2 | 2014 | 39 | 0.350 |
Why?
|
| Digoxin | 2 | 2004 | 24 | 0.300 |
Why?
|
| Glycolysis | 2 | 2016 | 79 | 0.280 |
Why?
|
| Cell Proliferation | 5 | 2020 | 1173 | 0.280 |
Why?
|
| Animals | 22 | 2022 | 20877 | 0.270 |
Why?
|
| Epidermal Growth Factor | 3 | 2013 | 95 | 0.270 |
Why?
|
| Enzyme Activation | 5 | 2020 | 791 | 0.250 |
Why?
|
| Aconitine | 1 | 2004 | 5 | 0.250 |
Why?
|
| Adrenal Cortex | 1 | 2004 | 8 | 0.250 |
Why?
|
| Neoplasms | 3 | 2022 | 1660 | 0.250 |
Why?
|
| ErbB Receptors | 5 | 2014 | 239 | 0.250 |
Why?
|
| Receptors, Nicotinic | 1 | 2004 | 41 | 0.240 |
Why?
|
| Helicobacter pylori | 3 | 2010 | 54 | 0.240 |
Why?
|
| Cilia | 3 | 2013 | 94 | 0.230 |
Why?
|
| Cells, Cultured | 8 | 2017 | 2673 | 0.230 |
Why?
|
| Rats | 9 | 2020 | 5300 | 0.230 |
Why?
|
| Oxygen Consumption | 2 | 2022 | 258 | 0.230 |
Why?
|
| Cell Cycle | 2 | 2022 | 312 | 0.220 |
Why?
|
| Heparin-binding EGF-like Growth Factor | 4 | 2014 | 17 | 0.210 |
Why?
|
| eIF-2 Kinase | 1 | 2022 | 49 | 0.210 |
Why?
|
| Carbon Monoxide | 1 | 2022 | 58 | 0.210 |
Why?
|
| Infant, Premature | 1 | 2003 | 284 | 0.200 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2020 | 93 | 0.190 |
Why?
|
| Mice | 12 | 2022 | 8472 | 0.190 |
Why?
|
| Acrylamides | 1 | 2020 | 12 | 0.190 |
Why?
|
| Neuropilin-2 | 1 | 2020 | 19 | 0.190 |
Why?
|
| Aniline Compounds | 1 | 2020 | 52 | 0.190 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2017 | 2083 | 0.190 |
Why?
|
| Vagus Nerve Stimulation | 2 | 2019 | 61 | 0.180 |
Why?
|
| Valsartan | 1 | 2020 | 99 | 0.180 |
Why?
|
| Aminobutyrates | 1 | 2020 | 94 | 0.180 |
Why?
|
| Adenosine Triphosphate | 2 | 2022 | 314 | 0.180 |
Why?
|
| Receptor, trkB | 1 | 2019 | 27 | 0.180 |
Why?
|
| Tetrazoles | 1 | 2020 | 160 | 0.180 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2020 | 155 | 0.170 |
Why?
|
| Homeobox Protein Nkx-2.5 | 1 | 2019 | 27 | 0.170 |
Why?
|
| Transcriptional Activation | 3 | 2010 | 226 | 0.170 |
Why?
|
| Sphingosine N-Acyltransferase | 1 | 2019 | 62 | 0.170 |
Why?
|
| Vagus Nerve | 1 | 2019 | 90 | 0.170 |
Why?
|
| Mitochondrial Proteins | 1 | 2019 | 113 | 0.170 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2020 | 331 | 0.170 |
Why?
|
| Endoplasmic Reticulum | 1 | 2019 | 148 | 0.170 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 4 | 2012 | 146 | 0.160 |
Why?
|
| Liver Neoplasms | 1 | 2022 | 334 | 0.160 |
Why?
|
| DNA Replication | 1 | 2019 | 167 | 0.160 |
Why?
|
| Stress, Physiological | 1 | 2019 | 215 | 0.160 |
Why?
|
| H(+)-K(+)-Exchanging ATPase | 2 | 2008 | 45 | 0.160 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2020 | 332 | 0.160 |
Why?
|
| Adrenergic Neurons | 1 | 2017 | 7 | 0.160 |
Why?
|
| Infant, Newborn | 1 | 2003 | 2453 | 0.150 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 2017 | 19 | 0.150 |
Why?
|
| Receptor for Advanced Glycation End Products | 1 | 2017 | 19 | 0.150 |
Why?
|
| Interleukin-1beta | 2 | 2008 | 88 | 0.150 |
Why?
|
| Nerve Growth Factor | 1 | 2017 | 54 | 0.150 |
Why?
|
| Kidney Diseases | 1 | 2020 | 307 | 0.150 |
Why?
|
| Arterioles | 1 | 2017 | 40 | 0.150 |
Why?
|
| Dopaminergic Neurons | 1 | 2017 | 46 | 0.150 |
Why?
|
| Parkinsonian Disorders | 1 | 2017 | 43 | 0.150 |
Why?
|
| Vasodilation | 1 | 2017 | 85 | 0.150 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2020 | 300 | 0.150 |
Why?
|
| Motor Neurons | 1 | 2017 | 98 | 0.150 |
Why?
|
| Adenine Nucleotide Translocator 2 | 1 | 2016 | 3 | 0.150 |
Why?
|
| Adenine Nucleotide Translocator 3 | 1 | 2016 | 3 | 0.150 |
Why?
|
| Locomotion | 1 | 2017 | 135 | 0.140 |
Why?
|
| Adenosine Diphosphate | 1 | 2016 | 66 | 0.140 |
Why?
|
| Protein Transport | 2 | 2019 | 280 | 0.140 |
Why?
|
| DNA | 1 | 2019 | 597 | 0.140 |
Why?
|
| Parkinson Disease | 1 | 2019 | 272 | 0.140 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2017 | 98 | 0.140 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2017 | 183 | 0.140 |
Why?
|
| Adipose Tissue | 1 | 2017 | 221 | 0.140 |
Why?
|
| Ethanol | 1 | 2022 | 892 | 0.130 |
Why?
|
| Mitochondria, Liver | 1 | 2016 | 148 | 0.130 |
Why?
|
| MAP Kinase Signaling System | 3 | 2013 | 247 | 0.130 |
Why?
|
| Membrane Proteins | 1 | 2019 | 617 | 0.130 |
Why?
|
| Integrin beta1 | 2 | 2012 | 48 | 0.130 |
Why?
|
| Mice, Knockout | 4 | 2019 | 1692 | 0.130 |
Why?
|
| Hepatocytes | 1 | 2016 | 205 | 0.130 |
Why?
|
| Glutamic Acid | 1 | 2017 | 332 | 0.120 |
Why?
|
| Coronary Vessels | 1 | 2017 | 313 | 0.120 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2015 | 86 | 0.120 |
Why?
|
| Cardenolides | 2 | 2004 | 4 | 0.120 |
Why?
|
| Ciliary Motility Disorders | 1 | 2013 | 3 | 0.120 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2013 | 10 | 0.120 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2015 | 145 | 0.120 |
Why?
|
| Blood Pressure | 1 | 2020 | 1447 | 0.120 |
Why?
|
| Neoplasm Proteins | 1 | 2016 | 307 | 0.120 |
Why?
|
| Calcium Channel Agonists | 1 | 2013 | 18 | 0.120 |
Why?
|
| TRPV Cation Channels | 1 | 2013 | 17 | 0.120 |
Why?
|
| TRPP Cation Channels | 1 | 2013 | 20 | 0.120 |
Why?
|
| Bronchiectasis | 1 | 2013 | 25 | 0.120 |
Why?
|
| Cell Membrane Permeability | 1 | 2013 | 59 | 0.120 |
Why?
|
| Cell Polarity | 1 | 2013 | 49 | 0.120 |
Why?
|
| Cell Differentiation | 2 | 2015 | 1034 | 0.120 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 1070 | 0.110 |
Why?
|
| Signal Transduction | 3 | 2017 | 2688 | 0.110 |
Why?
|
| Phosphorylation | 5 | 2020 | 1199 | 0.110 |
Why?
|
| Aquaporin 2 | 1 | 2011 | 4 | 0.110 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2017 | 626 | 0.110 |
Why?
|
| Receptors, Vasopressin | 1 | 2011 | 5 | 0.110 |
Why?
|
| Multiprotein Complexes | 1 | 2012 | 56 | 0.100 |
Why?
|
| Thiophenes | 1 | 2012 | 76 | 0.100 |
Why?
|
| Enzyme Inhibitors | 2 | 2016 | 659 | 0.100 |
Why?
|
| Protein Binding | 2 | 2012 | 1027 | 0.100 |
Why?
|
| Humans | 16 | 2022 | 68525 | 0.100 |
Why?
|
| Disease Models, Animal | 4 | 2019 | 2550 | 0.100 |
Why?
|
| Calcium | 2 | 2013 | 929 | 0.100 |
Why?
|
| Lung Neoplasms | 1 | 2020 | 1172 | 0.100 |
Why?
|
| Aging | 1 | 2017 | 911 | 0.100 |
Why?
|
| Coronary Artery Disease | 1 | 2017 | 696 | 0.100 |
Why?
|
| Receptor, PAR-2 | 1 | 2010 | 7 | 0.100 |
Why?
|
| Receptor, PAR-1 | 1 | 2010 | 30 | 0.100 |
Why?
|
| Hypertension | 1 | 2020 | 1531 | 0.100 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2012 | 167 | 0.090 |
Why?
|
| Disease | 1 | 2010 | 41 | 0.090 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2010 | 72 | 0.090 |
Why?
|
| Autophagy | 2 | 2022 | 207 | 0.090 |
Why?
|
| Stomach | 1 | 2010 | 80 | 0.090 |
Why?
|
| Telomerase | 1 | 2010 | 85 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2010 | 150 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2010 | 147 | 0.090 |
Why?
|
| Cell Line | 2 | 2011 | 1752 | 0.090 |
Why?
|
| Cell Culture Techniques | 1 | 2010 | 189 | 0.090 |
Why?
|
| Substrate Specificity | 1 | 2010 | 234 | 0.090 |
Why?
|
| Janus Kinases | 1 | 2009 | 11 | 0.090 |
Why?
|
| Kallikreins | 1 | 2010 | 323 | 0.090 |
Why?
|
| Sodium-Hydrogen Exchangers | 1 | 2009 | 43 | 0.090 |
Why?
|
| Calmodulin | 1 | 2009 | 53 | 0.080 |
Why?
|
| Sp1 Transcription Factor | 1 | 2008 | 21 | 0.080 |
Why?
|
| Oxidopamine | 2 | 2019 | 42 | 0.080 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2014 | 194 | 0.080 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2010 | 317 | 0.080 |
Why?
|
| Male | 8 | 2020 | 37281 | 0.080 |
Why?
|
| Neostriatum | 2 | 2019 | 60 | 0.080 |
Why?
|
| Locus Coeruleus | 2 | 2019 | 55 | 0.080 |
Why?
|
| Transforming Growth Factor alpha | 2 | 2014 | 30 | 0.080 |
Why?
|
| Substantia Nigra | 2 | 2019 | 102 | 0.080 |
Why?
|
| Norepinephrine | 2 | 2019 | 276 | 0.080 |
Why?
|
| Rats, Long-Evans | 2 | 2019 | 203 | 0.080 |
Why?
|
| Podocytes | 1 | 2009 | 113 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 3 | 2019 | 2790 | 0.080 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 282 | 0.070 |
Why?
|
| Ceramides | 2 | 2022 | 578 | 0.070 |
Why?
|
| Gastric Mucosa | 1 | 2007 | 77 | 0.070 |
Why?
|
| Helicobacter Infections | 1 | 2007 | 40 | 0.070 |
Why?
|
| Receptor, Serotonin, 5-HT2A | 1 | 2006 | 10 | 0.070 |
Why?
|
| Matrix Metalloproteinase 8 | 1 | 2006 | 22 | 0.070 |
Why?
|
| Collagenases | 1 | 2006 | 34 | 0.070 |
Why?
|
| Receptor, Bradykinin B2 | 1 | 2006 | 75 | 0.070 |
Why?
|
| Dopamine | 2 | 2019 | 474 | 0.070 |
Why?
|
| Transfection | 3 | 2017 | 782 | 0.070 |
Why?
|
| Heparin | 1 | 2006 | 205 | 0.070 |
Why?
|
| Transcription, Genetic | 1 | 2007 | 562 | 0.060 |
Why?
|
| Hexamethonium | 1 | 2004 | 4 | 0.060 |
Why?
|
| Mecamylamine | 1 | 2004 | 9 | 0.060 |
Why?
|
| Nicotinic Antagonists | 1 | 2004 | 11 | 0.060 |
Why?
|
| Physostigmine | 1 | 2004 | 14 | 0.060 |
Why?
|
| Morpholines | 1 | 2014 | 79 | 0.060 |
Why?
|
| Acetylcholine | 1 | 2004 | 64 | 0.060 |
Why?
|
| Radioimmunoassay | 1 | 2003 | 164 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2007 | 1745 | 0.060 |
Why?
|
| Inflammation | 1 | 2010 | 1030 | 0.060 |
Why?
|
| Fetal Blood | 1 | 2003 | 131 | 0.060 |
Why?
|
| Drug Synergism | 1 | 2004 | 260 | 0.060 |
Why?
|
| Gestational Age | 1 | 2003 | 389 | 0.050 |
Why?
|
| Polyploidy | 1 | 2022 | 24 | 0.050 |
Why?
|
| Acetaldehyde | 1 | 2022 | 18 | 0.050 |
Why?
|
| Disulfiram | 1 | 2022 | 22 | 0.050 |
Why?
|
| Voltage-Dependent Anion Channels | 1 | 2022 | 40 | 0.050 |
Why?
|
| Cell Respiration | 1 | 2022 | 47 | 0.050 |
Why?
|
| Molecular Docking Simulation | 1 | 2022 | 78 | 0.050 |
Why?
|
| DNA, Mitochondrial | 1 | 2022 | 84 | 0.050 |
Why?
|
| Biomarkers | 2 | 2019 | 1593 | 0.050 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2022 | 99 | 0.050 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2022 | 89 | 0.050 |
Why?
|
| Protein Kinases | 1 | 2022 | 122 | 0.050 |
Why?
|
| Immunoprecipitation | 2 | 2013 | 132 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2013 | 282 | 0.050 |
Why?
|
| Phenotype | 1 | 2014 | 946 | 0.050 |
Why?
|
| Hep G2 Cells | 1 | 2020 | 68 | 0.050 |
Why?
|
| Tacrolimus | 1 | 2022 | 127 | 0.050 |
Why?
|
| Cholesterol | 1 | 2022 | 331 | 0.050 |
Why?
|
| Nicotine | 1 | 2004 | 350 | 0.050 |
Why?
|
| Rats, Inbred Dahl | 1 | 2020 | 48 | 0.050 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2020 | 57 | 0.050 |
Why?
|
| A549 Cells | 1 | 2020 | 50 | 0.050 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2020 | 50 | 0.050 |
Why?
|
| Energy Metabolism | 1 | 2022 | 222 | 0.050 |
Why?
|
| Proteolysis | 1 | 2020 | 97 | 0.050 |
Why?
|
| Azepines | 1 | 2019 | 15 | 0.040 |
Why?
|
| Biphenyl Compounds | 1 | 2020 | 184 | 0.040 |
Why?
|
| CRISPR-Cas Systems | 1 | 2019 | 41 | 0.040 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2020 | 107 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2020 | 304 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2020 | 369 | 0.040 |
Why?
|
| Female | 4 | 2017 | 38015 | 0.040 |
Why?
|
| Lipid Metabolism | 1 | 2019 | 186 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 196 | 0.040 |
Why?
|
| Benzamides | 1 | 2019 | 156 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2022 | 595 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 710 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2020 | 331 | 0.040 |
Why?
|
| Luciferases | 2 | 2009 | 105 | 0.040 |
Why?
|
| Benzylamines | 1 | 2017 | 28 | 0.040 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2017 | 71 | 0.040 |
Why?
|
| Corpus Striatum | 1 | 2019 | 278 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2016 | 1849 | 0.040 |
Why?
|
| Cell Movement | 1 | 2020 | 630 | 0.040 |
Why?
|
| Oligodendroglia | 1 | 2017 | 107 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 2 | 2010 | 614 | 0.040 |
Why?
|
| Necrosis | 1 | 2017 | 239 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2019 | 328 | 0.040 |
Why?
|
| Diet, High-Fat | 1 | 2017 | 81 | 0.040 |
Why?
|
| Caveolin 1 | 1 | 2017 | 59 | 0.040 |
Why?
|
| Random Allocation | 1 | 2017 | 442 | 0.040 |
Why?
|
| RNA Interference | 1 | 2017 | 266 | 0.030 |
Why?
|
| Cell Self Renewal | 1 | 2015 | 13 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2015 | 100 | 0.030 |
Why?
|
| Phagocytosis | 1 | 2015 | 65 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2015 | 110 | 0.030 |
Why?
|
| Retinal Rod Photoreceptor Cells | 1 | 2015 | 71 | 0.030 |
Why?
|
| Apoptosis | 1 | 2022 | 1640 | 0.030 |
Why?
|
| Cattle | 1 | 2015 | 475 | 0.030 |
Why?
|
| Models, Biological | 1 | 2019 | 981 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 1032 | 0.030 |
Why?
|
| Bronchoconstrictor Agents | 1 | 2013 | 6 | 0.030 |
Why?
|
| Methacholine Chloride | 1 | 2013 | 20 | 0.030 |
Why?
|
| Mucociliary Clearance | 1 | 2013 | 21 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2017 | 384 | 0.030 |
Why?
|
| Cations, Divalent | 1 | 2013 | 27 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2009 | 1663 | 0.030 |
Why?
|
| Respiratory Mucosa | 1 | 2013 | 52 | 0.030 |
Why?
|
| Ion Channel Gating | 1 | 2013 | 42 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2013 | 137 | 0.030 |
Why?
|
| Adult | 2 | 2017 | 21375 | 0.030 |
Why?
|
| Age Factors | 1 | 2017 | 1860 | 0.030 |
Why?
|
| Isoquinolines | 1 | 2011 | 37 | 0.030 |
Why?
|
| Vasopressins | 1 | 2011 | 33 | 0.030 |
Why?
|
| Pregnancy | 1 | 2017 | 2331 | 0.030 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2011 | 93 | 0.030 |
Why?
|
| Sulfonamides | 1 | 2011 | 141 | 0.020 |
Why?
|
| Receptors, Thrombin | 1 | 2010 | 18 | 0.020 |
Why?
|
| EGF Family of Proteins | 1 | 2010 | 17 | 0.020 |
Why?
|
| Amphiregulin | 1 | 2010 | 19 | 0.020 |
Why?
|
| Enzyme Repression | 1 | 2010 | 3 | 0.020 |
Why?
|
| Obesity | 1 | 2017 | 1074 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2010 | 326 | 0.020 |
Why?
|
| Oligopeptides | 1 | 2010 | 152 | 0.020 |
Why?
|
| Receptor, ErbB-4 | 1 | 2009 | 13 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2009 | 196 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2010 | 238 | 0.020 |
Why?
|
| Brain | 1 | 2019 | 2175 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 4843 | 0.020 |
Why?
|
| 5' Flanking Region | 1 | 2007 | 8 | 0.020 |
Why?
|
| Risk Factors | 1 | 2017 | 5719 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2009 | 954 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2007 | 99 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2007 | 191 | 0.020 |
Why?
|
| Stomach Neoplasms | 1 | 2007 | 64 | 0.020 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2006 | 24 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2008 | 432 | 0.020 |
Why?
|
| Bradykinin | 1 | 2006 | 157 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2006 | 434 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2010 | 693 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2007 | 682 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2007 | 475 | 0.010 |
Why?
|
| Aged | 1 | 2017 | 14842 | 0.010 |
Why?
|
| Middle Aged | 1 | 2017 | 21119 | 0.010 |
Why?
|
| Time Factors | 1 | 2007 | 4655 | 0.010 |
Why?
|